首页|期刊导航|国际肝胆胰疾病杂志(英文版)|Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma:A multicenter study
Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma:A multicenter study
Dan-Dan Wang Jin-Feng Zhang Lin-Han Zhang Meng Niu Hui-Jie Jiang Fu-Cang Jia Shi-Ting Feng
国际肝胆胰疾病杂志(英文版)2023,Vol.22Issue(6):594-604,11.
国际肝胆胰疾病杂志(英文版)2023,Vol.22Issue(6):594-604,11.DOI:10.1016/j.hbpd.2022.11.005
Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma:A multicenter study
Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma:A multicenter study
摘要
关键词
Transarterial chemoembolization/Hepatocellular carcinoma/Radiomics/Machine learning/PredictionKey words
Transarterial chemoembolization/Hepatocellular carcinoma/Radiomics/Machine learning/Prediction引用本文复制引用
Dan-Dan Wang,Jin-Feng Zhang,Lin-Han Zhang,Meng Niu,Hui-Jie Jiang,Fu-Cang Jia,Shi-Ting Feng..Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma:A multicenter study[J].国际肝胆胰疾病杂志(英文版),2023,22(6):594-604,11.基金项目
This study was supported in part by grants from the National Key Research and Development Program(2019YFC0118100 and 2017YFC0110903),the National Natural Science Foundation of China(12026602 and 81802649),the Guangdong Key Area Re-search and Development Program(2020B010165004),the Shen-zhen Key Basic Science Program(JCYJ20180507182437217),and the Shenzhen Key Laboratory Program(ZDSYS201707271637577). (2019YFC0118100 and 2017YFC0110903)